1. Home
  2. ORMP vs WALD Comparison

ORMP vs WALD Comparison

Compare ORMP & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

HOLD

Current Price

$4.29

Market Cap

165.3M

Sector

Health Care

ML Signal

HOLD

Logo Waldencast plc

WALD

Waldencast plc

HOLD

Current Price

$1.67

Market Cap

187.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORMP
WALD
Founded
2002
1988
Country
United States
United Kingdom
Employees
N/A
364
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
165.3M
187.3M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ORMP
WALD
Price
$4.29
$1.67
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$2.00
AVG Volume (30 Days)
500.7K
664.0K
Earning Date
05-14-2026
03-13-2026
Dividend Yield
6.51%
N/A
EPS Growth
412.50
N/A
EPS
0.91
N/A
Revenue
$2,000,000.00
N/A
Revenue This Year
N/A
$9.89
Revenue Next Year
N/A
$4.31
P/E Ratio
$4.73
N/A
Revenue Growth
49.25
N/A
52 Week Low
$1.98
$0.72
52 Week High
$5.19
$3.22

Technical Indicators

Market Signals
Indicator
ORMP
WALD
Relative Strength Index (RSI) 51.34 53.23
Support Level $3.69 $1.47
Resistance Level $5.10 $1.95
Average True Range (ATR) 0.34 0.14
MACD 0.00 -0.01
Stochastic Oscillator 37.19 55.00

Price Performance

Historical Comparison
ORMP
WALD

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

About WALD Waldencast plc

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

Share on Social Networks: